Elon Musk Tries To Shut Down Drug Use Rumors With Negative Test Results, But Timeline Raises Eyebrows
Tech billionaire Elon Musk is shutting down allegations of drug use by posting his clean test results.
Musk was seemingly prompted to share his result after a publication had claimed that he frequently used ketamine and psychedelics.
While Elon Musk released the test results to discredit the drug claims, it has only further fueled more speculation, especially due to the short detection window.
Musk fired back at The New York Times following their recent allegations of his "intense" drug use by posting drug test results showing he's clean across the board.
On Tuesday, June 17, Musk shared a screenshot via X (formerly Twitter), captioning it with a simple "lol."
The test, conducted by Fastest Labs of South Austin, lists "Elon Musk" as the donor and shows negative results for a range of substances, including ketamine, ecstasy, cocaine, and amphetamines.
Notably, the test was taken on June 11, nearly two weeks after The Times published a report alleging that the former White House advisor frequently used ketamine and psychedelics while supporting Donald Trump's 2024 presidential campaign.
While Musk shared the results as a rebuttal to The Times, its credibility as a rebuttal has been called into question.
Fastest Labs' website notes a key limitation: "urine drug tests can detect drugs that have been ingested within the last 2-10 days."
A clinic employee confirmed this to People Magazine, explaining that most substances exit the system quickly, except cannabis, which tends to linger longer.
They also emphasized that hair follicle tests offer a much broader detection range, capable of identifying drug use dating back up to 90 days, making them a more reliable option for assessing long-term patterns of use.
Reactions to Musk's drug test results have been mixed, with many expressing skepticism about the validity.
One more person commented, "The richest man in the world does not have the resources to cheat a piss test? Give me a break."
Another said, "Ketamine stays in your blood like 48h if you're a daily user, Mfer, you're not the first to game a drug test."
A third person noted, "Now do the same test but with your hair.... a urine test only says you didn't have drugs the last couple of days."
The New York Times also hit back at his post, writing, "Elon Musk is continuing to lash out because he doesn't like our reporting. Nothing that he's said or presented since our article about his drug use during the presidential campaign was published contradicts what we uncovered. We stand by our journalism."
The test came in response to a May 30 New York Times article alleging Musk had been using ketamine frequently throughout 2024, to the point it was damaging his bladder.
The claims surfaced as Musk ramped up financial and public support for Donald Trump's reelection campaign, donating nearly $275 million. The report also stated that Musk carried a pill box containing Adderall and used other psychedelics.
During a joint press conference with Trump, Musk was asked about the Times' report. He dismissed the publication's credibility and told the reporter to "move on." Later, he reiterated via social media that he does not use drugs.
Meanwhile, President Trump, speaking to reporters near Air Force One, said he wasn't aware of any drug use by Musk. "I'm not troubled by anything with Elon," he stated at the time. "I think he's fantastic."
Meanwhile, Musk's relationship with President Trump has unraveled, coinciding with the end of his role as a "special government employee" on May 30, the same day The New York Times published its story on Musk's alleged drug use.
In the days that followed, the tech billionaire launched into a social media offensive that severely strained his ties with the president.
During the outburst, which spanned a few days, Musk harshly criticized Trump's proposed "One Big, Beautiful Bill," calling it a "disgusting abomination." He went further, claiming credit for Trump's 2024 election win and even accusing the president of concealing Jeffrey Epstein-related files to protect himself—an accusation Musk later deleted.
On June 5, when asked to respond to Musk's online attacks, Trump expressed dismay. "Elon and I had a great relationship," he said, pointedly using the past tense. "I don't know if we will anymore."
By June 11, Musk appeared to reconsider his remarks. In a post published on X around 3 a.m. ET, he admitted feeling "regret" and noted that some of his criticisms had "gone too far."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
15 minutes ago
- Fox News
Blue state GOP lawmakers urge major healthcare change for illegal immigrants
EXCLUSIVE: Colorado congressional Republicans are asking the state to stop allowing illegal immigrants to enroll in the state's Medicaid program, Health First Colorado. The program's availability to those in the country illegally who meet other requirements for coverage started this year, and the Republicans pitched changes in a letter to Democratic Gov. Jared Polis Wednesday. On Health First Colorado's website, it says, "Don't let immigration status stop you from applying for health coverage," citing state law. "Other Democrat-run states like California and Minnesota are beginning to walk back their policies that offer free and subsidized health care to illegal immigrants even without the One Big Beautiful Bill Act being law because they know that these policies are expensive, bad deals for their Medicaid beneficiaries," the letter from representatives Gabe Evans, Jeff Crank and Lauren Boebert states. "It is disheartening to see Colorado continue to double down and prioritize individuals who are unlawfully present even in the face of adverse impacts on Americans who need Medicaid the most, and we urge you to reverse course," the Republicans added. As the letter notes, Colorado is one of seven states that offer public healthcare coverage that does not factor in one's immigration status. California, Minnesota and Illinois are making reforms to their Medicaid offerings, according to The Wall Street Journal. Minnesota and Illinois are ending the availability as part of budget deals, and California is navigating different options, like a possible enrollment freeze, as its legislature hashes out a budget. In California, a recent poll revealed nearly 60% oppose Medicaid for illegal immigrants despite the law going into effect last year. The lawmakers added that the reconciliation bill includes a provision that will significantly penalize states that provide coverage to illegal immigrants because the Medicaid programs receive both federal and state taxpayer dollars. "There is a renewed urgency to revise this policy in light of the likely enactment of federal legislation to reduce the Medicaid [Federal Medical Assistance Percentage] for the expansion population from 90% to 80% for sanctuary states who use taxpayer dollars to cover illegal immigrants. As you know, this change would pose significant budgetary challenges to Colorado – but only if the state continues to pursue this policy," the letter states. A spokesperson for Polis' office told Fox News Digital in a statement that the reconciliation bill in the U.S. Senate should be completely redone from the House version. "Governor Polis is disappointed these three lawmakers are trying to gut Medicaid and kick people off private insurance, which would raise insurance costs for everyone who buys commercial insurance because of cost-shifting. Thanks to their votes — which they're trying to distract from — nearly 400,000 Coloradans would lose health care, which would also raise costs for everyone else," the statement said. "Governor Polis continues calling on the Senate to start from scratch with this terrible bill, including truly protecting Medicaid and extending critical subsidies for those who purchase plans off the health exchange so Coloradans can afford health care."
Yahoo
27 minutes ago
- Yahoo
Leona Maguire, four back at KPMG, still dealing with aftermath of tick bites at Erin Hills
FRISCO, Texas – Leona Maguire doesn't typically wear sun sleeves on the golf course. But, after suffering from several tick bites at the U.S. Women's Open at Erin Hills, the Irishwoman went on a round of doxycycline, and it has wreaked havoc on her skin. The medication is meant to reduce the chance of contracting Lyme disease, and she's just finished up the two-week treatment. She wore pants last week at the Meijer but couldn't bring herself to do it this week in steamy Texas. Advertisement 'It's made my skin like tissue paper,' said Maguire, who has a particularly nasty blood blister on her right hand that she said looks like a pepperoni. Her twin sister Lisa, who recently graduated from dental school, dressed the wound twice during Round 1 of the KPMG Women's PGA Championship. Maguire opened with an even-par 72 at Fields Ranch East course to sit four strokes back of leader Jeeno Thitikul. After four consecutive missed cuts, Maguire has found something with her driver after switching back to last year's model. She also went back to her old putter — almost. Maguire's Ping rep has always had a backup putter at his house that was identical to her longtime putter, and she asked him to bring it out to Texas this week. Advertisement For the last few weeks, she'd been trying a center-shafted putter. 'Sometimes, what do they say, a rest is as good as a change,' said Maguire. 'It's nice to have this familiar putter.' This article originally appeared on Golfweek: Leona Maguire still dealing with aftermath of tick bites at Erin Hills
Yahoo
28 minutes ago
- Yahoo
Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut
On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq's opening bell in New York, marking the company's awaited initial public offering. Housing market weakness triggers Lennar to offer biggest incentives since 2009 The Trump administration is trying to bring back asbestos How one company is revolutionizing the way we use everyday water The diagnostics company's IPO follows the successful debut of fintech companies like Chime Financial and Circle Internet Group, and will test whether investors are ready to embrace biotech companies despite declines in the sector for the last six months. Here's what to know about the listing. Founded in 2008 by David Dean Halbert, the healthcare company utilizes next-generation artificial intelligence (AI) and machine learning for precision medicine. Through molecular analysis, Caris specializes in cancer diagnosis and treatment. According to a recent filing to the Securities and Exchange Commission (SEC), the Irving, Texas-based company currently has over 1,700 employees and over 100 biopharmaceutical partners. The company incurred net losses of $281.9 million and $341.4 million in 2024 and 2023, respectively, on revenue of $412.3 million and $306.1 million. It is expecting additional losses in the future. Caris Life Sciences shares are expected to begin trading on Wednesday, June 18, with the offering expected to run through June 20. Caris Life Sciences will trade its stock under the ticker CAI. CAI shares were priced at $21, above their previously planned range. The IPO price was planned between the $19 and $20 range, up from the previous $16 and $18 planned price. The current pricing would value Caris Life Sciences at around $5.9 billion. CAI will trade its shared on the Nasdaq Global Select Market. Caris Life Sciences's IPO will offer 23,529,412 shares. Founder and CEO Halbert is also set to retain 41.7% of ownership following the IPO. This post originally appeared at to get the Fast Company newsletter: Sign in to access your portfolio